- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for CONMED Corp (CNMD)
| Open: | 33.2000 | Day's Range: | 33.0200 - 33.4600 | Volume: | 198,907 |
|---|---|---|---|---|---|
| Previous Close: | 33.2800 | 52wk Range: | 24.7800 - 34.4799 | 1-Yr Rtn: | +24.52% |
Key Statistics for CNMD
| Current P/E Ratio (ttm) | 17.8925 |
|---|---|
| Estimated P/E(12/2013) | 17.8637 |
| Relative P/E vs. SPX | 1.1074 |
| Earnings Per Share (USD) (ttm) | 1.8600 |
| Est. EPS (USD) (12/2013) | 1.8630 |
| Est. PEG Ratio | 1.3741 |
| Market Cap (M USD) | 934.33 |
| Shares Outstanding (M) | 28.07 |
| 30 Day Average Volume | 132,364 |
| Price/Book (mrq) | 1.5506 |
| Price/Sale (ttm) | 1.2406 |
| Dividend Indicated Gross Yield | 1.80% |
| Cash Dividend (USD) | 0.1500 |
| Last Dividend | 03/13/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CNMD
Company Profile & Key Executives for CNMD
CONMED Corporation provides orthopedic products, specializing in arthroscopy and powered surgical instruments. The Company develops, manufactures, and supplies surgical instruments and systems used in a range of surgical procedures. CON- MED's products include arthroscopic surgery devices and powered surgical instru- ments, electrosurgery systems, and ECG electrodes for heart monitoring.
| Joseph J CorasantiPresident/CEO | Luke A PomilioExec VP/Gen Manager/Controller |
| Robert D Shallish JrExec VP:Finance/CFO | William W AbrahamExec VP:Business Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CNMD News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page